Stephen From News Today

/PRNewswire/ -- Aruna Bio, Inc., a leader in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today...

/PRNewswire/ -- Aruna Bio, a leader in the development of neural exosomes for the treatment of neuro-inflammatory and neurodegenerative diseases, today...

/PRNewswire/ -- Aruna Bio, a leader in the development of neural exosomes for the treatment of neuro-inflammatory and neurodegenerative diseases, today...

Salt Lake City, Utah--(Newsfile Corp. - February 1, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced today the appointment of Erin Parsons as a new independent

12/13/21 Life Science Leader Newsletter

Confirm -EyeGate signs non-binding letter of intent to acquire Bayon Therapeutics, a private ophthalmic pharmaceutical company developing a novel, vision restoring small molecule platform- WALTHAM, Mass., July 26, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. ( EYEG), (“EyeGate” or the “Company”), a clinical-stage company developing and commercializing products for treating inflammatory and immune diseases with a focus on the eye and nervous system, today announced that Brian M...